# Performance of PEAR 2.0 Software in Prescribing Biotherapy in Patients With Rheumatoid Arthritis

> **NCT06186375** · — · ACTIVE_NOT_RECRUITING · sponsor: **CEN Biotech** · enrollment: 239 (actual)

## Conditions studied

- Polyarthritis; Rheumatoid

## Interventions

- **OTHER:** Patients with planned biotherapy

## Key facts

- **NCT ID:** NCT06186375
- **Lead sponsor:** CEN Biotech
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-05-05
- **Primary completion:** 2025-11-30
- **Final completion:** 2026-03-31
- **Target enrollment:** 239 (ACTUAL)
- **Last updated:** 2025-08-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06186375

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06186375, "Performance of PEAR 2.0 Software in Prescribing Biotherapy in Patients With Rheumatoid Arthritis". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06186375. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*